Constrictive pericarditis following mRNA COVID-19 vaccination in a patient with systemic sclerosis

• Published in: Journal of cardiology cases Vol. 26; no. 2; pp. 97 - 100
• Main Authors: Misumi, Ikuo, Ogata, Aki, Fukuda, Koichiro, Sato, Koji, Nagano, Miwa, Usuku, Hiroki, Tsujita, Kenichi
• Format: Report
• Language: English
• Published: 01.08.2022
• ISSN: 1878-5409
• DOI: 10.1016/j.jccase.2022.03.014

A 59-year-old man with systemic sclerosis and interstitial pneumonia was referred to our department because he developed dyspnea and leg edema after receiving a first shot of coronavirus disease 2019 (COVID-19) vaccine. Transthoracic echocardiography showed moderate pericardial effusion with conspicuous fibrin deposition. Prednisolone was increased from 6 mg/day for systemic sclerosis to 20 mg/day. Thereafter, pericardial effusion gradually decreased. However, his symptoms continued. Transthoracic echocardiography showed disappearance of pericardial effusion and thickened pericardium. Pulsed-wave and tissue Doppler echocardiography revealed that the patient suffered from newly developed constrictive pericarditis. COVID-19 vaccination might have contributed to acute pericarditis and subsequent constrictive pericarditis in the present case of systemic sclerosis and pulmonary fibrosis. Learning objectiveIncidence of adverse effects after coronavirus disease 2019 vaccination is rare. The present case suggests the risk of pericarditis that may lead to constrictive pericarditis.